期刊
CELL BIOLOGY AND TOXICOLOGY
卷 39, 期 1, 页码 111-143出版社
SPRINGER
DOI: 10.1007/s10565-022-09773-7
关键词
Hyperoxia; Reactive oxygen species; Oxygen toxicity; Mitochondria; Cell death; Antioxidants
Oxygen therapy is commonly used in clinical and non-clinical settings, but high oxygen levels can cause cell dysfunction or death, with long-term effects on development. This review discusses the impact of high oxygen on cellular activities and pathways, as well as strategies to mitigate injury.
In clinical settings, oxygen therapy is administered to preterm neonates and to adults with acute and chronic conditions such as COVID-19, pulmonary fibrosis, sepsis, cardiac arrest, carbon monoxide poisoning, and acute heart failure. In non-clinical settings, divers and astronauts may also receive supplemental oxygen. In addition, under current standard cell culture practices, cells are maintained in atmospheric oxygen, which is several times higher than what most cells experience in vivo. In all the above scenarios, the elevated oxygen levels (hyperoxia) can lead to increased production of reactive oxygen species from mitochondria, NADPH oxidases, and other sources. This can cause cell dysfunction or death. Acute hyperoxia injury impairs various cellular functions, manifesting ultimately as physiological deficits. Chronic hyperoxia, particularly in the neonate, can disrupt development, leading to permanent deficiencies. In this review, we discuss the cellular activities and pathways affected by hyperoxia, as well as strategies that have been developed to ameliorate injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据